Breast cancer and combined oral contraceptives: Results from the Collaborative Group on Hormonal Factors in Breast Cancer

Breast cancer and combined oral contraceptives: Results from the Collaborative Group on Hormonal Factors in Breast Cancer

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Beral, V, Reeves, G
Μορφή:	Conference item
Έκδοση:	1998

Παρόμοια τεκμήρια

Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.
ανά: Beral, V
Έκδοση: (1996)

Childbearing, oral contraceptive use, and breast cancer.
ανά: Beral, V, κ.ά.
Έκδοση: (1993)

CHILDBEARING, ORAL-CONTRACEPTIVE USE, AND BREAST-CANCER
ανά: Beral, V, κ.ά.
Έκδοση: (1993)

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
ανά: Beral, V
Έκδοση: (1997)

Breast cancer and hormonal contraceptives: Further results
ανά: Calle, E, κ.ά.
Έκδοση: (1996)

Breast cancer trends in women in Sweden, the UK, and the USA in relation to their past use of oral contraceptives
ανά: Beral, V, κ.ά.
Έκδοση: (1996)

Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case–control study and meta-analysis
ανά: Fitzpatrick, D, κ.ά.
Έκδοση: (2023)

Breast cancer and oral contraceptives--the evidence so far.
ανά: Reeves, G
Έκδοση: (1996)

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer.
ανά: Cancer, C
Έκδοση: (1996)

Breast Cancer Risk in Relation to Use of Combined and Progestogen-Only Contraceptives: Results from a UK Record-Linkage Study
ανά: Reeves, G, κ.ά.
Έκδοση: (2012)

Hormone Therapy, Breast Cancer Risk and the Collaborative Group on Hormonal Factors in Breast Cancer Article
ανά: Luciano de Melo Pompei, κ.ά.
Έκδοση: (2020-06-01)

Breast cancer and hormone exposure - Reply
ανά: Beral, V, κ.ά.
Έκδοση: (1996)

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct.
ανά: Banks, E, κ.ά.
Έκδοση: (2004)

Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.
ανά: Danielle Fitzpatrick, κ.ά.
Έκδοση: (2023-03-01)

Meta-analysis: Use of combined oral contraceptives in the past 10 years is associated with an increased risk for breast cancer
ανά: Beral, V
Έκδοση: (1996)

Oral contraceptives and menopausal hormone therapy as breast cancer risk categories
ανά: I. V. Vуsotskaya, κ.ά.
Έκδοση: (2019-09-01)

Oral contraceptives and breast cancer.
ανά: McPherson, K, κ.ά.
Έκδοση: (1983)

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct (multiple letters)
ανά: Banks, E, κ.ά.
Έκδοση: (2004)

Menopausal hormone therapy and 20-year breast cancer mortality
ανά: Beral, V, κ.ά.
Έκδοση: (2019)

AGE-SPECIFIC DIFFERENCES IN THE RELATION BETWEEN ORAL-CONTRACEPTIVE USE AND BREAST-CANCER
ανά: Wingo, P, κ.ά.
Έκδοση: (1990)

Age-specific differences in the relationship between oral contraceptive use and breast cancer.
ανά: Wingo, P, κ.ά.
Έκδοση: (1993)

Age-specific differences in the relationship between oral contraceptive use and breast cancer.
ανά: Wingo, P, κ.ά.
Έκδοση: (1991)

Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
ανά: Beral, V, κ.ά.
Έκδοση: (1997)

Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
ανά: Beral, V, κ.ά.
Έκδοση: (2011)

Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies
ανά: Calle, E, κ.ά.
Έκδοση: (1996)

Impact of hormone replacement therapy on breast cancer
ανά: Gathani, T, κ.ά.
Έκδοση: (2010)

Breast cancer and hormone-replacement therapy: the Million Women Study - Reply
ανά: Beral, V, κ.ά.
Έκδοση: (2003)

Variations in the Prevalence of Risk Factors for Breast Cancer in Different Ethnic Groups in the Million Women Study
ανά: Gathani, T, κ.ά.
Έκδοση: (2012)

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.
ανά: Beral, V, κ.ά.
Έκδοση: (2008)

Breast cancer and hormone-replacement therapy in the Million Women Study.
ανά: Beral, V
Έκδοση: (2003)

Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries.
ανά: Beral, V, κ.ά.
Έκδοση: (2004)

Hormone replacement therapy increase breast cancer incidence and may increase breast cancer mortality in postmenopausal women
ανά: Beral, V, κ.ά.
Έκδοση: (2004)

Oral contraceptives and the small increased risk of breast cancer
ανά: Hunter, D
Έκδοση: (2017)

BREAST-CANCER AND THE ESTROGEN CONTENT OF ORAL-CONTRACEPTIVES - REPLY
ανά: Mcpherson, K, κ.ά.
Έκδοση: (1984)

Oral contraceptives and the small increased risk of breast cancer
ανά: Hunter, D
Έκδοση: (2017)

Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women
ανά: Urban, M, κ.ά.
Έκδοση: (2013)

Early oral contraceptive use and breast cancer: results of another case-control study.
ανά: McPherson, K, κ.ά.
Έκδοση: (1987)

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
ανά: Reeves, G, κ.ά.
Έκδοση: (2006)

Oral contraceptives and breast cancer. A prospective cohort study.
ανά: Lipnick, R, κ.ά.
Έκδοση: (1986)

Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk
ανά: Satish S, κ.ά.
Έκδοση: (2023-03-01)